 | • レポートコード：D0804-16351 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、PCRおよびNGSベース分子診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。PCRおよびNGSベース分子診断の種類別市場規模（バイオマーカー探索、血液サンプル検査、その他）、用途別市場規模（病院、学術・研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermofisher、Pillar Biosciences、Roche、Illumine、Agilent、Paragon Genomics、iGen Technologies、Bioo Scientific、Qiagen、LC-Bio Technologies (Hangzhou) CO. LTD.、Burning Rock ・地域別グローバル市場分析 2015年-2020年 ・PCRおよびNGSベース分子診断の北米市場（アメリカ、カナダ、メキシコ） ・PCRおよびNGSベース分子診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・PCRおよびNGSベース分子診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・PCRおよびNGSベース分子診断の南米市場（ブラジル、アルゼンチン） ・PCRおよびNGSベース分子診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：バイオマーカー探索、血液サンプル検査、その他 ・用途別分析：病院、学術・研究機関、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global PCR and NGS-Based Molecular Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The PCR and NGS-Based Molecular Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
PCR and NGS-Based Molecular Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, PCR and NGS-Based Molecular Diagnostics market has been segmented into:
Biomarker Discovery
Blood Sample Testig
Others
By Application, PCR and NGS-Based Molecular Diagnostics has been segmented into:
Hospitals
Academics/Research Institutions
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global PCR and NGS-Based Molecular Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level PCR and NGS-Based Molecular Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global PCR and NGS-Based Molecular Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the PCR and NGS-Based Molecular Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and PCR and NGS-Based Molecular Diagnostics Market Share Analysis
PCR and NGS-Based Molecular Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, PCR and NGS-Based Molecular Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the PCR and NGS-Based Molecular Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in PCR and NGS-Based Molecular Diagnostics are:
Thermofisher
Pillar Biosciences
Roche
Illumine
Agilent
Paragon Genomics
iGen Technologies
Bioo Scientific
Qiagen
LC-Bio Technologies (Hangzhou) CO. LTD.
Burning Rock
Table of Contents
1 PCR and NGS-Based Molecular Diagnostics Market Overview
1.1 Product Overview and Scope of PCR and NGS-Based Molecular Diagnostics
1.2 Classification of PCR and NGS-Based Molecular Diagnostics by Type
1.2.1 Global PCR and NGS-Based Molecular Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type in 2019
1.2.3 Biomarker Discovery
1.2.4 Blood Sample Testig
1.2.5 Others
1.3 Global PCR and NGS-Based Molecular Diagnostics Market by Application
1.3.1 Overview: Global PCR and NGS-Based Molecular Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Academics/Research Institutions
1.3.4 Others
1.4 Global PCR and NGS-Based Molecular Diagnostics Market by Regions
1.4.1 Global PCR and NGS-Based Molecular Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of PCR and NGS-Based Molecular Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) PCR and NGS-Based Molecular Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) PCR and NGS-Based Molecular Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) PCR and NGS-Based Molecular Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) PCR and NGS-Based Molecular Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) PCR and NGS-Based Molecular Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermofisher
2.1.1 Thermofisher Details
2.1.2 Thermofisher Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermofisher SWOT Analysis
2.1.4 Thermofisher Product and Services
2.1.5 Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pillar Biosciences
2.2.1 Pillar Biosciences Details
2.2.2 Pillar Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pillar Biosciences SWOT Analysis
2.2.4 Pillar Biosciences Product and Services
2.2.5 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Roche SWOT Analysis
2.3.4 Roche Product and Services
2.3.5 Roche PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Illumine
2.4.1 Illumine Details
2.4.2 Illumine Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Illumine SWOT Analysis
2.4.4 Illumine Product and Services
2.4.5 Illumine PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Agilent
2.5.1 Agilent Details
2.5.2 Agilent Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Agilent SWOT Analysis
2.5.4 Agilent Product and Services
2.5.5 Agilent PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Paragon Genomics
2.6.1 Paragon Genomics Details
2.6.2 Paragon Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Paragon Genomics SWOT Analysis
2.6.4 Paragon Genomics Product and Services
2.6.5 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 iGen Technologies
2.7.1 iGen Technologies Details
2.7.2 iGen Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 iGen Technologies SWOT Analysis
2.7.4 iGen Technologies Product and Services
2.7.5 iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bioo Scientific
2.8.1 Bioo Scientific Details
2.8.2 Bioo Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bioo Scientific SWOT Analysis
2.8.4 Bioo Scientific Product and Services
2.8.5 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Qiagen
2.9.1 Qiagen Details
2.9.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Qiagen SWOT Analysis
2.9.4 Qiagen Product and Services
2.9.5 Qiagen PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 LC-Bio Technologies (Hangzhou) CO. LTD.
2.10.1 LC-Bio Technologies (Hangzhou) CO. LTD. Details
2.10.2 LC-Bio Technologies (Hangzhou) CO. LTD. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 LC-Bio Technologies (Hangzhou) CO. LTD. SWOT Analysis
2.10.4 LC-Bio Technologies (Hangzhou) CO. LTD. Product and Services
2.10.5 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Burning Rock
2.11.1 Burning Rock Details
2.11.2 Burning Rock Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Burning Rock SWOT Analysis
2.11.4 Burning Rock Product and Services
2.11.5 Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global PCR and NGS-Based Molecular Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 PCR and NGS-Based Molecular Diagnostics Players Market Share
3.2.2 Top 10 PCR and NGS-Based Molecular Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global PCR and NGS-Based Molecular Diagnostics Revenue and Market Share by Regions
4.2 North America PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
5 North America PCR and NGS-Based Molecular Diagnostics Revenue by Countries
5.1 North America PCR and NGS-Based Molecular Diagnostics Revenue by Countries (2015-2020)
5.2 USA PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe PCR and NGS-Based Molecular Diagnostics Revenue by Countries
6.1 Europe PCR and NGS-Based Molecular Diagnostics Revenue by Countries (2015-2020)
6.2 Germany PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Revenue by Countries
7.1 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Revenue by Countries (2015-2020)
7.2 China PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
8 South America PCR and NGS-Based Molecular Diagnostics Revenue by Countries
8.1 South America PCR and NGS-Based Molecular Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue PCR and NGS-Based Molecular Diagnostics by Countries
9.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global PCR and NGS-Based Molecular Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global PCR and NGS-Based Molecular Diagnostics Market Forecast by Type (2019-2024)
10.3 Biomarker Discovery Revenue Growth Rate (2015-2025)
10.4 Blood Sample Testig Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global PCR and NGS-Based Molecular Diagnostics Market Segment by Application
11.1 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Application (2015-2020)
11.2 PCR and NGS-Based Molecular Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Academics/Research Institutions Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global PCR and NGS-Based Molecular Diagnostics Market Size Forecast (2021-2025)
12.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Forecast (2021-2025)
12.2 Global PCR and NGS-Based Molecular Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America PCR and NGS-Based Molecular Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe PCR and NGS-Based Molecular Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America PCR and NGS-Based Molecular Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global PCR and NGS-Based Molecular Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of PCR and NGS-Based Molecular Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global PCR and NGS-Based Molecular Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermofisher Corporate Information, Location and Competitors
Table 6. Thermofisher PCR and NGS-Based Molecular Diagnostics Major Business
Table 7. Thermofisher PCR and NGS-Based Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Thermofisher SWOT Analysis
Table 9. Thermofisher PCR and NGS-Based Molecular Diagnostics Product and Solutions
Table 10. Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pillar Biosciences Corporate Information, Location and Competitors
Table 12. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Major Business
Table 13. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. Pillar Biosciences SWOT Analysis
Table 15. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product and Solutions
Table 16. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Roche Corporate Information, Location and Competitors
Table 18. Roche PCR and NGS-Based Molecular Diagnostics Major Business
Table 19. Roche PCR and NGS-Based Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. Roche SWOT Analysis
Table 21. Roche PCR and NGS-Based Molecular Diagnostics Product and Solutions
Table 22. Roche PCR and NGS-Based Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Illumine Corporate Information, Location and Competitors
Table 24. Illumine PCR and NGS-Based Molecular Diagnostics Major Business
Table 25. Illumine PCR and NGS-Based Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Illumine SWOT Analysis
Table 27. Illumine PCR and NGS-Based Molecular Diagnostics Product and Solutions
Table 28. Illumine PCR and NGS-Based Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Agilent Corporate Information, Location and Competitors
Table 30. Agilent PCR and NGS-Based Molecular Diagnostics Major Business
Table 31. Agilent PCR and NGS-Based Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Agilent SWOT Analysis
Table 33. Agilent PCR and NGS-Based Molecular Diagnostics Product and Solutions
Table 34. Agilent PCR and NGS-Based Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Paragon Genomics Corporate Information, Location and Competitors
Table 36. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Major Business
Table 37. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. Paragon Genomics SWOT Analysis
Table 39. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product and Solutions
Table 40. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. iGen Technologies Corporate Information, Location and Competitors
Table 42. iGen Technologies PCR and NGS-Based Molecular Diagnostics Major Business
Table 43. iGen Technologies PCR and NGS-Based Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. iGen Technologies SWOT Analysis
Table 45. iGen Technologies PCR and NGS-Based Molecular Diagnostics Product and Solutions
Table 46. iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bioo Scientific Corporate Information, Location and Competitors
Table 48. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Major Business
Table 49. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. Bioo Scientific SWOT Analysis
Table 51. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product and Solutions
Table 52. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Qiagen Corporate Information, Location and Competitors
Table 54. Qiagen PCR and NGS-Based Molecular Diagnostics Major Business
Table 55. Qiagen PCR and NGS-Based Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. Qiagen SWOT Analysis
Table 57. Qiagen PCR and NGS-Based Molecular Diagnostics Product and Solutions
Table 58. Qiagen PCR and NGS-Based Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. LC-Bio Technologies (Hangzhou) CO. LTD. Corporate Information, Location and Competitors
Table 60. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Major Business
Table 61. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 62. LC-Bio Technologies (Hangzhou) CO. LTD. SWOT Analysis
Table 63. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product and Solutions
Table 64. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Burning Rock Corporate Information, Location and Competitors
Table 66. Burning Rock PCR and NGS-Based Molecular Diagnostics Major Business
Table 67. Burning Rock PCR and NGS-Based Molecular Diagnostics Total Revenue (USD Million) (2017-2018)
Table 68. Burning Rock SWOT Analysis
Table 69. Burning Rock PCR and NGS-Based Molecular Diagnostics Product and Solutions
Table 70. Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 72. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Players (2015-2020)
Table 73. Global PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 74. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Regions (2015-2020)
Table 75. North America PCR and NGS-Based Molecular Diagnostics Revenue by Countries (2015-2020)
Table 76. North America PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Table 77. Europe PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 79. South America PCR and NGS-Based Molecular Diagnostics Revenue by Countries (2015-2020)
Table 80. South America PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Table 83. Global PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 84. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Type (2015-2020)
Table 85. Global PCR and NGS-Based Molecular Diagnostics Revenue Forecast by Type (2021-2025)
Table 86. Global PCR and NGS-Based Molecular Diagnostics Revenue by Application (2015-2020)
Table 87. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Application (2015-2020)
Table 88. Global PCR and NGS-Based Molecular Diagnostics Revenue Forecast by Application (2021-2025)
Table 89. Global PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. PCR and NGS-Based Molecular Diagnostics Picture
Figure 2. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type in 2019
Figure 3. Biomarker Discovery Picture
Figure 4. Blood Sample Testig Picture
Figure 5. Others Picture
Figure 6. PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Academics/Research Institutions Picture
Figure 9. Others Picture
Figure 10. Global PCR and NGS-Based Molecular Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Players in 2019
Figure 18. Global Top 5 Players PCR and NGS-Based Molecular Diagnostics Revenue Market Share in 2019
Figure 19. Global Top 10 Players PCR and NGS-Based Molecular Diagnostics Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 23. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Regions in 2018
Figure 24. North America PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 25. Europe PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. South America PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. North America PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 30. North America PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 31. USA PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 32. Canada PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. Mexico PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Europe PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 35. Europe PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 36. Germany PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 37. UK PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. France PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. Russia PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. Italy PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 43. China PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 44. Japan PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Korea PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. India PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. South America PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 49. South America PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 50. Brazil PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 51. Argentina PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 55. UAE PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. Egypt PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. South Africa PCR and NGS-Based Molecular Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Type (2015-2020)
Figure 59. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Type in 2019
Figure 60. Global PCR and NGS-Based Molecular Diagnostics Market Share Forecast by Type (2021-2025)
Figure 61. Global Biomarker Discovery Revenue Growth Rate (2015-2020)
Figure 62. Global Blood Sample Testig Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Application (2015-2020)
Figure 65. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Application in 2019
Figure 66. Global PCR and NGS-Based Molecular Diagnostics Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Academics/Research Institutions Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global PCR and NGS-Based Molecular Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America PCR and NGS-Based Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 74. Europe PCR and NGS-Based Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 76. South America PCR and NGS-Based Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa PCR and NGS-Based Molecular Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
分子インフルエンザ診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Influenza Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Molecular Infl…- 組織ベース診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Tissue-Based Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 分子生物学用分析装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Molecular Biology Analyzers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Molecular Biology…
- カートリッジベースポイントオブケア診断システムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Cartridge Based Point of Care Diagnostics System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players…
- カートリッジベースポイントオブケア診断システムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Cartridge Based Point of Care Diagnostics System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players…